Exchange: NASDAQ·Updated 04:10 PM EDT
IMA logo

IMA ImageneBio, Inc.

$4.85
$0.035
(0.72%)
Today
Closed $4.85
$0.00
(0.00%)
After Hours
Reported EarningsAug 5
Mkt Cap$55.45M
Vol15,462.00

About IMA

ImageneBio, Inc. is a clinical-stage biotechnology company that boldly imagines a world where patients can be free from the burden of grievous immunological/autoimmune and inflammatory (I&I) diseases. It focuses on the development of new medicines with differentiated profiles that can effectively control and change the course of I&I diseases for affected patients, treat their symptoms, and improve quality of life. The company was founded in February 2016, and is headquartered in San Diego, CA.
60

Bullish Sentiment

How do you feel about IMA?

Advertisement|Remove ads.